April 2024 | Deals & Transactions
Conyers Advises NYSE Listed Nuvation Bio Inc. on its Acquisition of AnHeart Therapeutics Ltd.
April 2024 | Deals & Transactions
Conyers Advises NYSE Listed Nuvation Bio Inc. on its Acquisition of AnHeart Therapeutics Ltd.
February 2024 | Deals & Transactions
Conyers advises Digicel on Bermuda schemes of arrangements pursuant to US$3.8 billion cross-border restructuring
January 2024 | Deals & Transactions
Conyers Advises Quantinuum on its US$300 Million Equity Fundraise In Series A Financing Round
November 2023 | Deals & Transactions
Conyers Advises GLAAM and Captivision on Their Business Combination with Nasdaq-Listed Jaguar Global Growth Corporation I
September 2023 | Deals & Transactions
Conyers Advises Golden Star on Its Proposed Business Combination with Gamehaus Inc.
May 2023 | Deals & Transactions
Conyers Advises Inflection Point Acquisition Corp. II on US$220 Million IPO
May 2023 | Deals & Transactions
Conyers Advises Lindblad Expeditions Holdings, LLC on Its Issue of US$275 Million 9.00% Senior Secured Notes
March 2023 | Deals & Transactions
Conyers Advises GLAAM Co., Ltd on Proposed Business Combination with Jaguar Global Growth Corporation I
December 2022 | Deals & Transactions
Conyers advises Finnish tech company MariaDB on the completion of its business combination with the SPAC vehicle Angel Pond Holdings Corp.
Stay current with our latest legal insights: subscribe today